• Agnieszka Owczarczyk-Saczonek Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn
  • Prof. Waldemar Place Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn


Obesity is a growing problem in most developed countries and is responsible for a significant degree of morbidity and mortality. Based on the WHO recommendations, BMI between 25 and 29.99 indicates overweight; BMI above than or equal to 30 indicates obesity, and BMI above than or equal to 40 points shows severe or morbid obesity. Clinically, obesity is defined as the accumulation of excess body fat to the extent that it may have adverse effects on health. 

            The consequences of obesity is not only an increased risk of cardiovascular disease, diabetes, and cancer development, but also the occurrence of disorders affecting the skin and subcutaneous tissue. It causes a dysfunction of the epidermal-dermal barrier (secondary superinfection), increased secretion of sebum and sweat (↑ pH of sweat and the skin), abnormal micro- and macrocirculation, lymph circulation and delayed wound healing. These disturbations are the skin disorders related to insulin resistance (acanthosis nigricans, acrochordons, keratosis pilaris, hyperandrogenism, hirsutism), predisposition to mechanical injuries (plantar keratosis, stretch marks, cellulitis, lymphatic edema, chronic venous insufficiency) and secondary infections (intertrigo infections, yeast and fungal infections, bacterial inflammation of subcutaneous tissue). However obesity can exacerbate some diseases including psoriasis, acne inversa, gout, chronic venous insufficiency.

            The purpose of this article is to highlight the association between obesity and dermatologic conditions. We presented skin diseases related to insulin resistance and secondary infections due to obesity.


I. Duarte, G.V., Cavalheiro, C.A.M., and de Oliveira, M.F. (2010) Psoriasis and obesity: literature review and recommendations for management. Anais Brasileiros de Dermatologia, 85, p. 355-360.

II. World Health Organization: The challenge of obesity in the WHO European Region. Fact sheet EURO 2005, 13, p. 1-4.

III. Romero-Corral, A., Somers, V.K., Sierra-Johnson, J., et al. (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. International Journal of Obesity, 32, p. 959–966.

IV. Tobin, A.M., Ahern, T., Rogers, S., et al. (2013) The dermatological consequences of obesity. International Journal of Dermatology, 52, p. 927-932.

V. Flegal, K.M., Carroll, M.D., Ogden, C.L., and Curtin, L.R. (2010) Prevalence and trends in obesity among US adults, 1999–2008. Journal of the American Medical Association, 303, p. 235–241.

VI. Pi-Sunyer, F.X. (2002) The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research, 10, p. 97-104.

VII. Xu, M.Y., Cao, B., Wang, D.F., et al. (2015) Human Adenovirus 36 infection increased the risk of obesity: a meta-analysis update. Medicine (Baltimore, 94, p. 2357.

VIII. Guida, B., Nino, M., Perrino, N.R., et al. (2010) The impact of obesity on skin disease and epidermal permeability barrier status. Journal of the European Academy of Dermatology and Venereology, 24, p. 191-195.

IX. Li P, Jin H, Liu D et al. (2005) Study on the effect of leptin on fibroblast proliferation and collagen synthesis in vitro in rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 19, p. 20–22.

X. Loffler, H., Aramaki, J.U., and Effendy, I. (2002) The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Research Technology, 8, p. 19–22.

XI. Nino, M., Franzese, A., Ruggiero Perrino, N., and Balato, N. (2012) The effect of obesity on skin disease and epidermal permeability barrier status in children. Pediatric Dermatology, 29, p. 567-570.

XII. Zouboulis CC. (2004) Acne and sebaceous gland function. Clinics in Dermatology, 22, p. 360-366.

XIII. Cappel, M., Mauger, D., and Thiboutot, D. (2005) Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Archives Dermatology, 141, p. 333-338.

XIV. Kumari, R., Thappa, D. (2013) Role of insulin resistance and diet in acne. Indian Journal of Dermatology, Venereology and Leprology, 79, p. 291-299.

XV. Pochi, P.E., Downing, D.T., and Strauss, J.S. (1970) Sebaceous gland response in man to prolonged total caloric deprivation. Journal of Investigative Dermatology, 55, p. 303-309.

XVI. Yosipovitch, G., DeVore, A., and Dawn, A. (2007) Obesity and the skin: skin physiology and skin manifestations of obesity. Journal of the American Academy Dermatology, 56, p. 901-916.

XVII. Semkova, K., Gergovska, M., Kazandjieva, J., et al. (2015) Hyperhidrosis, bromhidrosis, and chromhidrosis: fold (intertriginous) dermatoses. Clinics in Dermatology, 33, p. 483-491.

XVIII. Plascencia Gómez, A., Vega Memije, M.E., Torres Tamayo, M., et al. (2014) Skin disorders in overweight and obese patients and their relationship with insulin. Actas Dermosifiliograficas, 105, p. 178-185.

XIX. Boza, J.C., Trindade, E.N., Peruzzo, J., et al. (2012) Skin manifestations of obesity: a comparative study. Journal of the European Academy of Dermatology and Venereology, 26, p. 1220-1223.

XX. Divyashree, R.A., Naveen, K.N., Pai, V.V., et al. (2014) Cutaneous manifestations of obesity among dermatology patients in a tertiary care center. Indian Journal of Dermatology, Venereology and Leprology, 80, p. 278.

XXI. Brown, J., Wimpenny, P., and Maughan, H. (2004) Skin problems in people with obesity. Nursing Stanard, 18, p. 38-42.

XXII. Schwartz, R.A., and Janniger, E.J. (2011) Acanthosis nigricans – a common significant disorder usually unassociated with malignancy. Przegląd Dermatologiczny, 98, p. 1–6.

XXIII. Barbato, M.T., Criado, P.R., Silva, A.K., et al. (2012) Association of acanthosis nigricans and skin tags with insulin resistance. Anais Brasileiros de Dermatologia, 87, p. 97-104.

XXIV. Napolitano, M., Megna, M., and Monfrecola, G. (2015) Insulin resistance and skin diseases. Scientific World Journal, 2015, p. 479354.

XXV. Phiske, M.M. (2014) An approach to acanthosis nigricans. Indian Dermatology Online Journal, 5, p. 239–249.

XXVI. Hud, J.A. Jr, Cohen, J.B., Wagner, J.M., et al. (1992) Prevalence and significance of acanthosis nigricans in an adult obese population. Archives Dermatology, 128, p. 941-944.

XXVII. Wild, R.A. (1995) Obesity, lipids, cardiovascular risk, and androgen excess. American Journal of Medicine, 98, p. 27–32.

XXVIII. Ng, H.Y., Young, J.H., Huen, K.F., et al. (2014) Acanthosis nigricans in obese Chinese children. Hong Kong Medical Journal, 20, p. 290-296.

XXIX. El Safoury, O.S., Ezzat, M., Abdelhamid, M.F., et al. (2013) The evaluation of the impact of age, skin tags, metabolic syndrome, Body Mass Index, and smoking on homocysteine, endothelin-1, high-sensitive C-reactive protein, and on the heart. Indian Journal of Dermatology, 58, p. 326.

XXX. Kishan Kumar, Y.H., Sujatha, C., Ambika, H., et al. (2012) Penile acrochordon: an unusual site of presentation- a case report and review of the literature. International Journal of Health and Allied Sciences, 1, p. 122-125.

XXXI. Owczarczyk-Saczonek, A., and Placek, W. (2016) Skin tags as a symptom of metabolic disorders. Przegląd Dermatologiczny, 103, p. 240–245.

XXXII. Rajput, D.A., Gedam, J.K., Patel, A., et al. (2013) Dermatology. Unusual presentation of acrochordon. Indian Journal of Clinical Practice, 24, p. 436-438.

XXXIII. Schwartz, R.A., Tarlow, M.M., and Lambert, W.C. (2004) Keratoacanthoma-like squamous cell carcinoma within the fibroepithelial polyp. Dermatologic Surgery, 30, p. 349-350.

XXXIV. Jowkar, F., and Fallahi Anamazi, M.R. (2010) Is there any relation between serum insulin and insulin-like growth factor-i in non-diabetic patients with skin tag? Journal of the European Academy of Dermatology and Venereology, 24, p. 73-74.

XXXV. Bakry, O.A., Samaka, R.M., Shoeib, M.A., et al. (2014) Immunolocalization of androgen receptor and estrogen receptors in skin tags. Ultrastructural Patholology, 38, p. 344-357.

XXXVI. El Safoury, O., Rashid, L., and Ibrahim, M. (2010) A study of androgen and estrogen receptors α, β in skin tags. Indian Journal of Dermatology, 55, p. 20–24.

XXXVII. Stallmeyer, B., Kampfer, H., Podda, M., et al. (2001) A novel keratinocyte mitogen: regulation of leptin and its functional receptors in skin repair. Journal of Investigative Dermatology, 117, p. 98–105.

XXXVIII. El Safoury, O.S., Fawzy, M.M., Hay, R.M., et al. (2011) The possible role of trauma in skin tags through the release of mast cell mediators. Indian Journal of Dermatology, 56, p. 641-646.

XXXIX. da Silva, E.Z., Jamur, M.C., and Oliver, C. (2014) Mast cell function: a new vision of an old cell. Journal of Histochemistry and Cytochemistry ,62, p. 698-738.

XL. Dianzani, C., Calvieri, S., Pierangeli, A., et al. (1998) The detection of human papillomavirus DNA in skin tags. British Journal of Dermatology, 138, p. 649-651.

XLI. Gupta, S., Aggarwal, R., Gupta, S., et al. (2008) Human papillomavirus and skin tags: is there any association? Indian Journal of Dermatology, Venereology and Leprology, 74, p. 222-225.

XLII. Pasquali, R., and Vicennati V. (2001) Obesity and hormonal abnormalities. in: International Textbookof Obesity. Bjorntorp, P., (ed.), John Wiley & Sons Ltd, p. 225-238.

XLIII. Azziz, R., Sanchez, L.A., Knochenhauer, E.S., et al. (2004) Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology and Metabolism, 89, p. 453-462.

XLIV. Krzyżanowska-Świniarska, B. Simple obesity. in: Szczeklik's Internal Medicine Textbook of internal medicine, Medycyna Praktyczna, Kraków, 2012, p.1369-1373.

XLV. Olszanecka-Glinianowicz, M., Zahorska-Markiewicz, B., Żak-Gołąb, A., et al. (2005). The effect of moderate weight loss on hormonal profile in obese women with polycystic ovary. Endocrinology, Obesity, Metabolic Disorder, 1, p. 1–5.

XLVI. Melnik, B.C., John, S.M., and Plewig, G. (2013) Acne: risk indicator for increased body mass index and insulin resistance. Acta Dermato-Venereologica, 93, p. 644-649.

XLVII. Ruutiainen, K., Erkkola, R., Gronroos, M.A., et al. (1988) Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages. Fertility and Sterility, 50, p. 260-265.

XLVIII. Picardo, M., Ottaviani, M., Camera, E., et al. (2009) Sebaceous gland lipids. Dermato-endocrinology, 1, p. 68-71.

XLIX. Yang, C.C., Hsieh, F.N., Lin, L.Y., et al. (2014) Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. Journal of the American Academy Dermatology, 70, p. 297-302

L. Mirmirani, P., and Carpenter, D.M. (2014) The impact of obesity on the folliculosebaceous unit. Journal of the American Academy Dermatology, 71, p. 584-585.

LI. Hirsso, P., Rajala, U., Hiltunen, L., et al. (2007) Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology, 214, p. 125-129.

LII. Gopinath, H., and Upadya, G.M. (2016) Metabolic syndrome in androgenic alopecia. Indian Journal of Dermatology, Venereology and Leprology,82, p. 404-408.

LIII. Ozbas Gok, S., Belli, A.A., and Dervis, E. (2015) Is There really relationship between androgenic alopecia and metabolic syndrome? Dermatol Res Pract, 2015, p. 980310.

LIV. Lesko, S.M., Rosenberg, L., and Shapiro, S. (1993) A case-control study of baldness in relation to myocardial infarction in men. Journal of the American Medical Association, 269, p. 998–1003.

LV. Park, S.Y., Oh, S.S., and Lee, W.S. (2016) Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans. Journal of Dermatology, Mar 30. [Epub ahead of print]

LVI. Azziz, R., Carmina, E., Dewailly, D., et al. (2006) Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism, 91, p. 4237-4245.

LVII. Jalilian, A., Kiani, F., Sayehmiri, F., et al. (2015) Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a meta-analysis. Iranian Journal of Reproductive Medicine, 13, p. 591-604.

LVIII. Agapova, S.E., Cameo, T., Sopher, A.B., et al. (2014) Diagnosis and challenges of polycystic ovary syndrome in adolescence. Seminars in Reproductive Meicine, 32, p. 194-201.

LIX. Mor, E., Zograbyan, A., Saadat, P., Bayrak, A., et al. (2004) The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. American Journal of Obstetrics and Gynecology, 190, p. 1654-1660.

LX. Ward, R.C., Costoff, A., and Mahesh, V.B. (1978) The induction of polycystic ovaries in mature cycling rats by the administration of dehydroepiandrosterone (DHA). Biology of Reproduction, 18, p. 614-623.

LXI. Bakry, O.A., El Farargy, S.M., Ghanayem, N., et al. (2015) Atherogenic index of plasma in non-obese women with androgenetic alopecia. International Journal of Dermatology, 54, p. 339-344.

LXII. Beitz, J.M. (2014) Providing quality skin and wound care for the bariatric patient: an overview of clinical challenges. Ostomy Wound Management, 60, p. 12-21.

LXIII. Huttunen, R., and Syrjänen, J. (2013) Obesity and the risk and outcome of infection. International Journal of Obesity, 37, p. 333–340.

LXIV. Davidovici, B.B., Sattar, N., Jörg, P.C., et al. (2010) Psoriasis and systemic inflammatory disease: potential mechanistic links between skin disease and co-morbid conditions. Journal of Investigative Dermatology, 130, p. 1785-1796.

LXV. Shipman, A.R., Millington, G.W. (2011) Obesity and the skin. British Journal of Dermatology, 165, p. 743-50.

LXVI. Francis, K.R., Lamaute, H.R., Davis, J.M., et al. (1993) Implications of risk factors in necrotizing fasciitis. American Surgery, 59, p. 304-308.

Additional Files



How to Cite

Agnieszka Owczarczyk-Saczonek, & Prof. Waldemar Place. (2016). SKIN LESION AND DISEASES IN OBESITY - PART I: THE SKIN DISORDERS RELATED TO INSULIN RESISTANCE AND SECONDARY INFECTIONS. International Education and Research Journal (IERJ), 2(12). Retrieved from